The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD‐related
cirrhosis in the United States and globally highlights the need to better understand the …

Lipotoxicity drives the development of progressive hepatic inflammation and fibrosis in a
subgroup of patients with nonalcoholic fatty liver disease (NAFLD), causing nonalcoholic …

Abstract Objective This EAS Consensus Panel critically appraised evidence relevant to the
benefit to risk relationship of functional foods with added plant sterols and/or plant stanols …

Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum
ranging from simple steatosis to non-alcoholic steatohepatitis (NASH): NAFLD causes an …

Emerging experimental and human evidence has linked altered hepatic cholesterol
homeostasis and free cholesterol (FC) accumulation to the pathogenesis of non-alcoholic …

Increased blood cholesterol is an independent risk factor for atherosclerotic cardiovascular
disease. Cholesterol homeostasis in the body is controlled mainly by endogenous synthesis …

Patients with nonalcoholic fatty liver disease (NAFLD) often have dyslipidemia along with
other features of metabolic syndrome such as obesity, diabetes mellitus, and hypertension …

AIM: To investigate whether central obesity is associated with nonalcoholic fatty liver
disease (NAFLD) formation after adjusting for general obesity. METHODS: The online …

We recently reported that cholesterol crystals form in hepatocyte lipid droplets (LDs) in
human and experimental nonalcoholic steatohepatitis. Herein, we assigned WT C57BL/6J …

The efficacy of phytosterols and phytostanols added to foods and food supplements to
obtain significant non-pharmacologic serum and low density lipoprotein (LDL) cholesterol …